In vitro studies in INS-1 cells reveal that TFEB overexpression exerts a protective effect against glucolipotoxic cell death [201], demonstrating the significance of changes in TFEB expression and activity during T2D. This evidence concerns the gene TFEB and type 2 diabetes mellitus.